Comparison of cytochrome P-450 content and activities in liver microsomes of seven animal species, including man

References

• Azria M., Kiger J.L. Intéret du pore miniature en recherche biomédicale. Thérapie 1972; 27: 723–732
   Google Scholar
• Beaufay H., Amar-Costesec A., Feytmans E., Thines-Sempoux D., Wibo M., Robbi M., Berthet J. Analytical study of microsomes and isolated subcellular membranes from rat liver. Journal of Cell Biology 1974; 61: 213–231
   PubMed Web of Science ®Google Scholar
• Beaune Ph., Kremers P., Le Provost E., Cresteil Th., Gielen J.E. Monooxygenase activities in human liver microsomes. Biochemistry, Biophysics and Regulation of Cytochrome P-450, J.A. Gustafsson, Colleagues. Elsevier, Amsterdam 1980; 89–920
   Google Scholar
• Boobis A.R., Davies D.S. Human Cytochromes P-450. Xenobiotica 1984; 14: 151–185
   PubMed Web of Science ®Google Scholar
• Boobis A.R., Brodie M.J., Kahn D.R., Fletscher J.H., Saunders J.H., Davis D.S. Monoxygenase activity of human liver in microsomal fractions of needle biopsy. British Journal of Clinical Pharmacology 1980; 9: 11–19
   PubMed Web of Science ®Google Scholar
• Boobis A.R., Brodie M.J., Lewis K.M., Pacifici G.M., Kahn G.C., Davies D.S. (1980) Abstracts of the First World Conference on Clinical Pharmacology and Therapeutics. 1980. LondonUK, No. 0730
   Google Scholar
• Boobis A.R., Brodie M.J., Kahn G.C., Toverud E.L., Blair I.A., Murray S., Davies D.S. British Journal of Clinical Pharmacology 1981; 12: 771
   PubMedGoogle Scholar
• Boutin J.A., Antoine B., Batt A.M., Siest G. Heterogeneity of hepatic microsomal UDP-glucuronosyltransferase(s) activities: Comparison between human and mammalian species activities. Chemico-Biological Interactions 1984; 52: 173–184
   PubMed Web of Science ®Google Scholar
• Davies D.S., Thorgeirsson S.S. Mechanism of drug oxidation and its relation to individual differences in rates of oxidation in man. Annals of the New York Academy of Sciences 1971; 179: 411–420
   PubMedGoogle Scholar
• Dodds W.J. The Pig model for biomedical research. Federation Proceedings; Federation of American Societies for Experimental Biology 1982; 41: 247–256
   Google Scholar
• Dooley J.F. The role of clinical chemistry in chemical and drug safety evaluation by use of laboratory animals. Clinical Chemistry 1979; 25: 345–347
   PubMed Web of Science ®Google Scholar
• Freudenthal R.J., Leber P., Emmerling D., Kerchner G., Campbell D. Characterization of the hepatic microsomal mixed-function oxidase enzyme system in miniature pigs. Drug Metabolism and Disposition 1976; 4: 25–27
   PubMed Web of Science ®Google Scholar
• Golan M.D., Bücker M., Schmassmann H.V., Raphael D., Jung R., Bindel U., Brase H.O., Tegtmeyer F., Friedberg T., Lorenz J., Stasiecki P., Oesch F. Characterisation of dog hepatic drug metabolizing enzymes and resultant effects on benzo(a)pyrene metabolite pattern and mutagenicity. Drug Metabolism and Disposition 1980; 8: 121–126
   PubMed Web of Science ®Google Scholar
• Guengerich F.P. Separation on purification of multiple forms of microsomal cytochrome P-450. Journal of Biological Chemistry 1978; 253: 7931–7939
   PubMed Web of Science ®Google Scholar
• Hietanen E., Vainio H. Drug Metabolism, Chemical and Biochemical Aspects. Drugs and the Pharmaceutical Sciences, B. Testa, P. Jenner. Dekker, New York 1976; 444
   Google Scholar
• Hietanen E., Vainio H. Role of extrahepatic metabolism. Concept in Drug Metabolism, Part A, P. Jenner, B. Testa. Dekker, New York 1980; 251–284
   Google Scholar
• Journal Officiel, République Francaise 1976; 7365, (23 Décembre), Relative aux prélèvements d'organes, Loi no. 76, 1181
   Google Scholar
• Journal Officiel, République Francaise 1978; 1497, (4 Avril), Relative aux prélèvements d'organes, Décret no. 78, 501
   Google Scholar
• Kremers P., Beaune Ph., Cresteil, De Graeve J., Columelli S., Leroux J.P., Gielen J.F. Cytochrome P-450 monoxygenase activities in human and rat liver microsomes. European Journal of Biochemistry 1981; 118: 599–606
   PubMedGoogle Scholar
• Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Makowski R., Davies R., Gibson G.G. Species differences in cyt. P-450 and their corresponding messenger RNA's. Drug Metabolism and Drug Interactions 1982; 4: 129–171
   Google Scholar
• Nebert D.W., Gelboin H.V. Substrate inducible microsomal aryl hydrocarbon hydroxylase in mammalian cell culture. 1. Assay and properties of induced enzyme. Journal of Biological Chemistry 1968; 240: 6242–6249
   Google Scholar
• Nebert D.W., Gelboin H.V. In vivo and in vitro induction of aryl hydrocarbon hydroxylase in mammalian cells of different species, tissues, strains, and developmental and hormonal states. Archives of Biochemistry and Biophysics 1969; 134: 76–89
   PubMed Web of Science ®Google Scholar
• Netter K.J., Seidel B. Kinetic studies of oxidative demethylation of p-nitroanisole by rat liver microsomes. Journal of Pharmacology and Experimental Therapeutics 1964; 146: 61–66
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. 1. Evidence for its protein. Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Smith R.L. Genetic polymorphism of drug oxidation in man. Microsomes and Drug Oxidations, A.R. Boobis, J. Caldwell, F. De Matteis, C.R. Elcombe. Taylor & Francis, London 1985; 349–360
   Google Scholar
• Strobel H.W., Dignam J.D. Purification and properties of NADPH-Cytochrome P-450 reductase. Methods in Enzymology, S.E. Fleischer, L. Packer. Academic Press, London 1978; 52: 89–96
   Google Scholar
• Strolin-Benedetti M. Comparaison entre espèces dans les réactions de Phase 1 et de Phase 2 du métabolisme des xénobiotiques: métabolisme et conception des médicaments. Quo Vadis: Drug Metabolism and Drug Design: Quo Vadis, Clin Midy, Montpellier 1981; 57–88
   Google Scholar
• Ullrich V., Weber P. The O-dealkylation of 7-ethoxycoumarine by liver microsomes. Hoppe Seyler's Zeitschrift für Physiologische Chemie 1972; 353: 1171–1177
   PubMedGoogle Scholar
• Von Bahr C., Groth C.G., Jansson H., Lundgren G., Lind M., Glaumann H. Drug metabolism in human liver in vitro. Establishment of a human liver bank. Clinical Pharmacology and Therapeutics 1980; 27: 711–725
   PubMed Web of Science ®Google Scholar
• Yang C.S., Strickhart F.S. Inhibition of hepatic mixed function oxidase activity by propyl gallate. Biomedical Pharmacology 1974; 23: 3129–3138
   Google Scholar